Australia: Supporting evidence in patent specifications

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australia: Supporting evidence in patent specifications

The recent Full Federal Court case of Morellini v Mizzi Family Holdings Pty Ltd [2016] FCAFC 13 has highlighted the danger of using unsupported assertions in patent specifications.

The technology of the case dealt with sugar cane planting, with the applicant committing a fatal error in asserting: "it is found that" inclining a soil mound by about 40 degrees provided superior warming of the soil by the sun.

During prosecution, the applicant had argued the soil mound inclination was a significant feature of the claim that distinguished it from the prior art.

The problem was that there was no evidence that the soil mound incline had any effect on heating of the soil. The applicant tried to argue that this was part of their "own experience and conclusions". However the Court rejected this argument as totally speculative.

The Court concluded the patent was invalid for false suggestion or misrepresentation. Hence, the applicant's somewhat innocuous use of the term "it has been found", rather than say "it is conjectured, thought or believed", has led to the destruction of its patent rights.

The obvious takeaway from the case is to review specifications to revise assertions that are not backed by evidence.

treloar.jpg

Peter Treloar


Shelston IPLevel 21, 60 Margaret StreetSydney NSW 2000, AustraliaTel: +61 2 9777 1111Fax: +61 2 9241 4666email@shelstonip.comwww.shelstonip.com

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article